BREAKING: HRSA Awards 340B Prime Vendor Agreement to Apexus

The Health Resources and Services Administration (HRSA) announced this morning that it has awarded the 340B Prime Vendor Agreement to Apexus LLC after a competitive bid process.

“The 340B Prime Vendor will continue to support the distribution of covered outpatient drugs through the 340B Drug Pricing Program and as a resource to 340B stakeholders,” HRSA said in a brief notice on the Office of Pharmacy Affairs homepage. The notice directs readers to “get more information and technical assistance via the 340B Prime Vendor Program.”